Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1332 results

Challenging routes for TAVI

21 Nov 2021 – From PCR London Valves 2021

Watch this PCR London Valves 2021 session to look at transfemoral TAVR in patient with severe stenosis of iliac artery, to appreciate a transfemoral aortic valve replacement in a patient affected by abdomen aorta barrage, and more!

Challenging routes for TAVI

Coronaries and TAVI

21 Nov 2021 – From PCR London Valves 2021

Watch this series of videos and learn about TAVR in rheumatic patient with aortic regurgitation, IVUS assessment of coronary ostia following transapical ViV TAVI, "Hybrid thinking" off-pump CABG and TAVI for left main disease and CTO with severe aortic stenosis, and more!

Coronaries and TAVI

TAVI complications

21 Nov 2021 – From PCR London Valves 2021

Watch this session from PCR London Valves 2021 to appreciate the hybrid management of double aortic root rupture complicating TAVI, learn about an unexpected cause for complication during TAVR, investigate acute left main occlusion during TAVI, and much more!

TAVI complications

TAVI valve and implantation technique: the secrets for optimising outcomes

21 Nov 2021 – From PCR London Valves 2021

Join Neil Moat, Helge Möllmann, Lars Søndergaard and Ganesh Manoharan to hear the experience of an account achieve single digit permanent pacemaker implantation, to learn how to preserve coronary access for future patients' treatment, and to see how new product features can reduce paravalvular leak.

TAVI valve and implantation

Closing TAVI with next generation suture mediated closure device

21 Nov 2021 – From PCR London Valves 2021

Join Francesco Maisano to learn more about about the Perclose ProStyle, a next generation closure device for TAVI procedures, and discover some interesting tips & tricks.

Closing TAVI with next

Clinical scenarios

21 Nov 2021 – From PCR London Valves 2021

The PCR London Valves 2021 session offers a variety of interesting clinical scenarios, including a chimney stent as a coronary protection technique in TAVI, an acquired thrombocytopenia after TAVR to predict adverse outcomes, or even a calcified raphe predict adverse effect in bicuspid aortic stenosis patients...

Clinical scenarios

Patient-specific implantation technique to obtain neo-commissural alignment with self-expanding transcatheter aortic valves (COMALIGN)

21 Nov 2021 – From PCR London Valves 2021

Join Lars Søndergaard and Ole De Backer if you want to learn about why patient-specific implantation techniques are important to obtain commissural alignment, which imaging techniques are needed to achieve commissural alignment, as well as how valve and delivery system designs impact outcomes and success rates.

Patient-specific implantation

Early neo2 registry - Full core-lab adjudicated results with the new ACURATE neo2 valve

21 Nov 2021 – From PCR London Valves 2021

Join Won-Keun Kim and Andreas Rück if you want to learn about the key features of the new ACURATE neo2 system, the latest clinical outcomes in an all-comers European patient population, as well as the independent core-lab adjudicated hemodynamic performance of this new TAVI generation.

Early neo2 registry -

Aortic valve disease: treatment and patient selection

21 Nov 2021 – From PCR London Valves 2021

Let's talk about severe asymptomatic aortic stenosis: what are the surgical standpoint and recent data from surgical literature? How to assess these patients? How to analyze CT? What do the newly published VHD Guidelines say? What is the place of MRI in these patients? So many questions...

Aortic valve disease: treatment and patient selection

SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

07 Nov 2021

Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...

Paola Redaelli

Author

Paola Redaelli
M. Pighi

Author

Michele Pighi
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis

07 Nov 2021

Professor David J. Cohen presented the results of the economic outcomes of the PARTNER 3 trial on Friday, 5 November, in the Late-Breaking Trial session of the Transcatheter Cardiovascular Therapeutics Congress 2021. Giuseppe Biondi-Zoccai provides his analysis of this study.

Giuseppe Biondi Zoccai

Author

Giuseppe Biondi-Zoccai
PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis

CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure

06 Nov 2021

TCT 2021: Radoslaw Parma reviews the CHOICE-CLOSURE multicentre, randomized, controlled, open-label clinical trial presented by Mohamed Abdel-Wahab. The study compared outcomes of percutaneous femoral artery closure using a plug-based and a primary suture-based strategy in patients undergoing TAVI.

Author

Radoslaw Parma
CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure

PCRonline @ TCT 2021 - Get the international perspective!

03 Nov 2021

Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2021 - check out the list here!

PCRonline @ TCT 2021

ACTIVATION (percutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): a randomized clinical trial

19 Oct 2021

In conducting the ACTIVATION trial, Redwood and colleagues seek to complement the existing literature with high-level evidence on whether percutaneous coronary intervention (PCI) prior to TAVR is non-inferior to conservative (no PCI) management.

Rafail Angelos Kotronias

Reviewer

Rafail Angelos Kotronias

Reviewer

Salvatore Brugaletta
ACTIVATION (percutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): a randomized clinical trial

PCR TV: Valve selection considerations for the Heart Team

11 Oct 2021

Which valve for which patient? The question is no longer just whether to choose a balloon-expandable or a self-expanding valve: low-risk indications, increasing number of TAVI procedures, and growing complexity of patients are leading the TAVI community to become more prescriptive and to take time to...

PCR TV Valve selection considerations for the Heart Team

Cases on valvular disease

08 Oct 2021 – From AICT AsiaPCR 2021

Watch this session to discover various interesting cases on valvular disease, such as the implantation of a transcatheter aortic VIV for an acute AR in prior bio Bentall operation, the percutaneous pulmonic balloon valvuloplasty in a carcinoid pulmonic stenosis, as well as the percutaneous valve-in-valve in the...

Cases on valvular disease

Abstracts on TAVI

08 Oct 2021 – From AICT AsiaPCR 2021

Watch this session to discover a selection of abstracts on TAVI, and learn more about the operator preference and determinants of size when additional intermediate-size aortic THVs available, the comparative quantitative aortographic assessment of regurgitation in six self-expanding valves, as well as the chronic hemodynamic performance...

Abstracts on TAVI

TAVI in Asia-Pacific 2021: an update

08 Oct 2021 – From AICT-AsiaPCR 2021

Watch this session to be updated on the state of TAVI in 2021, especially in the Asia-Pacific Region, and learn more about the essential steps of TAVI procedure in a bicuspid valve.

TAVI in Asia-Pacific 2021: an update

Best cases and research unveiled at AICT-Asia PCR 2021

08 Oct 2021 – From AICT-AsiaPCR 2021

Watch this session to discover some of the best cases and research unveiled at AICT-Asia PCR 2021: positive remodelling of coronary arteries on CT coronary angiogram, investigation of heavy metals in coronary artery tissues in autopsy cases, DEB vs. DES in the main vessel for treatment of...

Best cases and research

Complications: calcified LM-LAD PCI, CHIP and TAVI

08 Oct 2021 – From AICT-AsiaPCR 2021

Watch this session on complications to see 3 clinical cases: "calcified LM-LAD PCI with rotablator", "cascading events in a CHIP case" and "complications in TAVI", and discover how they managed to face them. 

Complications: calcified